AMFI - Registered Mutual Fund Distributor

Corona Remedies Limited IPO

Corona Remedies Limited IPO

₹ 14868 / 14 Shares Shares
Minimum Investment

Corona Remedies Limited IPO

Issues Price

₹1008-1062 per equity share

Corona Remedies Limited IPO

Open Date

08 Dec 2025

Close Date

10 Dec 2025

Lot Size

14

Min. Investment

₹ 14868

Issue Price

₹1008-1062

Listing Date

15 Dec 2025

Issues Size

61,71,101 shares(aggregating up to ₹655.37 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

14 Shares

Offered To Public

14 Shares

Corona Remedies Limited IPO

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.

Founded In

2004

Managing Director

Dr. Kirtikumar Laxmidas Mehta

Parent Organization

Corona Remedies Limited IPO

Application Details of Corona Remedies Limited IPO.

Apply as Price Range Apply Upto
Retail (min) ₹1008-1062 ₹14,868
Retail(max) ₹1008-1062 ₹1,93,284
SHNI(min) ₹1008-1062 ₹2,08,152
SHNI(max) ₹1008-1062 ₹9,96,156
BHNI(min) ₹1008-1062 ₹10,11,024

For Corona Remedies Limited IPO, eligible investors can apply as Regular.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.7 Out of 5 (4442 Reviews)

Mutual fund investing with KSquare has been fantastic. I appreciate their attention to risk profiling and how they tailor recommendations. It’s an empowering experience.

Kavya Iyer

Kavya Iyer

Biotech Researcher

I started SIPs for my daughter’s education through KSquare, and the structured savings plan has given me peace of mind. Their transparent approach keeps my progress always clear and motivating.

Meera Nair

Meera Nair

KSquare’s NRI Corner made investing from abroad incredibly simple. The guidance was crystal clear, and their support team always kept me informed. Highly recommend this service for all NRIs!

Rahul Nanda

Rahul Nanda

IT Consultant

KSquare helped me invest in Indian markets with zero stress. Their NRI Corner is truly designed for people living abroad.

Ira D’Souza

Ira D’Souza

Startup Advisor

KSquare not only alerts about NFOs, but they explain fund purpose and performance projections. I truly appreciate that extra layer of detail and care.

Aditya Chauhan

Aditya Chauhan

Systems Engineer

As someone new to investing, KSquare’s SIP guidance has been incredibly helpful. Their platform is user-friendly, and the support team answered all my questions patiently.

Neha Gupta

Neha Gupta

HR Specialist

My dream vacation finally happened through planned SIP savings with KSquare. They track progress regularly and make sure goals never slip. A wonderful financial planning experience for every family.

Sana Khan

Sana Khan

KSquare’s NPS support was practical and transparent. They helped me compare options and choose what’s best for my future.

Naveen Thakkar

Naveen Thakkar

Chartered Accountant

I appreciate the balance of automation and control KSquare gives. Their fund research and regular updates give me confidence in every investment decision I make.

Mayank Verma

Mayank Verma

Business Analyst

I love how KSquare offers mutual fund plans that match my income flow and future goals. They’ve made saving and investing seamless for me.

Nirali Parekh

Nirali Parekh

Clinical Dietician

FAQ's

Frequenlty Asked Question

Are mutual funds suitable for short-term goals?

Debt and liquid funds are ideal for short-term goals, while equity funds are better for long-term wealth creation.

How does SIP-to-SWP second income planning work?

SIPs help build a corpus first, later converted to monthly withdrawable income through SWP, ensuring reliable financial independence

What’s the minimum investment required in an NFO?

Most NFOs start with a minimum investment of ₹500 or ₹1,000. KSquare clearly shows these details for each offering.

What is the interest rate for LAMF through KSquare?

Interest rates vary by lender and profile, but KSquare offers competitive rates starting as low as 9% annually with minimal processing fees.

Why should I choose KSquare over other platforms for NRI investing?

KSquare offers tailored advice, easy KYC, global access, compliance support, and personal service for NRI investors.

Can I open multiple NPS accounts?

No, you’re allowed only one NPS Tier I account, which is linked to your Permanent Retirement Account Number (PRAN).

Are mutual funds taxable in India?

Yes, mutual funds are subject to capital gains tax. Taxation depends on the type of fund and holding period.

Is there a processing fee for LAMF through KSquare?

A nominal processing fee may apply depending on the lender. KSquare clearly discloses all charges upfront.

App Store